Bacterial aetiology and mortality in COPD patients with CAP: results from the German Competence Network, CAPNETZ

被引:9
作者
Braeken, D. C. W. [1 ,2 ]
Franssen, F. M. E. [1 ,2 ]
von Baum, H. [3 ]
Schuette, H. [4 ,5 ]
Pletz, M. W. [5 ,6 ]
Rupp, J. [5 ,7 ]
Stassen, F. [8 ]
Mooij, M. J. [8 ]
Rohde, G. G. U. [2 ,5 ]
机构
[1] CIRO, Dept Res & Educ, Horn, Netherlands
[2] MUMC, Dept Resp Med, POB 5800, NL-6202 AZ Maastricht, Netherlands
[3] Univ Hosp Ulm, Dept Med Microbiol & Hyg, Ulm, Germany
[4] Ernst Bergmann Klinikum, Dept Internal Med Infect Dis & Resp Med, Potsdam, Germany
[5] CAPNETZ Stiftung, Hannover, Germany
[6] Jena Univ Hosp, Ctr Dis & Infect Control, Jena, Germany
[7] Univ Lubeck, Dept Mol & Clin Infect Dis, Lubeck, Germany
[8] MUMC, Dept Med Microbiol, Maastricht, Netherlands
关键词
chronic lung disease; microbiology; pathogen detection; respiratory infections; survival; COMMUNITY-ACQUIRED PNEUMONIA; OBSTRUCTIVE PULMONARY-DISEASE; INHALED CORTICOSTEROIDS; DIAGNOSIS; SEVERITY; OUTCOMES;
D O I
10.5588/ijtld.16.0567
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BACKGROUND: Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality, and chronic obstructive pulmonary disease (COPD) is a frequent comorbidity. The bacterial aetiology of CAPCOPD and its possible associations with serum markers and mortality are incompletely understood. OBJECTIVES: 1) To assess the bacterial aetiology of CAP only and CAP-COPD, and 2) to study the association between bacterial aetiology, empirical antibiotic treatment, serum markers and mortality. METHODS: Of 1288 patients with CAP (57.0% males, age 59.0 years +/- 18.5), 262 (20.3%) fulfilled the diagnostic criteria for COPD. Differences between subgroups were investigated using univariate analyses and corrected for multiple comparisons. RESULTS: Streptococcus pneumoniae was the most common pathogen (30.8% CAP only vs. 26.0% CAPCOPD, not significant). Haemophilus influenzae was significantly more frequent in CAP-COPD (5.6% CAP-SUMMARY only vs. 26.0% CAP-COPD, P < 0.001). The number given adequate empirical antibiotic treatment was comparable (83.3% CAP only vs. 83.6% CAP-COPD, P > 0.05). The CAP-COPD group had worse CURB-65 and partial pressure of arterial oxygen levels than the CAP only group (P < 0.001). Partial pressure of arterial carbon dioxide levels were increased in CAP-COPD patients without pathogen detection (P < 0.001). Short (P = 0.011) and long-term mortality (P = 0.006) were highest in CAP-COPD without pathogen detection. CONCLUSION: It is important to identify COPD patients with CAP. In particular, those without bacterial pathogen detection have more severe CAP and are at higher risk of dying. Better understanding of the aetiology could contribute to improved management and treatment of CAP in COPD patients.
引用
收藏
页码:236 / 243
页数:8
相关论文
共 35 条
[1]   CRB-65 predicts death from community-acquired pneumonia [J].
Bauer, T. T. ;
Ewig, S. ;
Marre, R. ;
Suttorp, N. ;
Welte, T. .
JOURNAL OF INTERNAL MEDICINE, 2006, 260 (01) :93-101
[2]   Increased Severity and Mortality of CAP in COPD: Results from the German Competence Network, CAPNETZ [J].
Braeken, Dionne C. W. ;
Franssen, Frits M. E. ;
Schutte, Hartwig ;
Pletz, Mathias W. ;
Bals, Robert ;
Martus, Peter ;
Rohde, Gernot G. U. .
CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2015, 2 (02) :131-140
[3]   Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease [J].
Calverley, Peter M. A. ;
Anderson, Julie A. ;
Celli, Bartolome ;
Ferguson, Gary T. ;
Jenkins, Christine ;
Jones, Paul W. ;
Yates, Julie C. ;
Vestbo, Jorgen ;
Calverley, P. M. A. ;
Anderson, J. A. ;
Celli, B. ;
Ferguson, G. T. ;
Jenkins, C. ;
Jones, P. W. ;
Knobil, K. ;
Yates, J. C. ;
Vestbo, J. ;
Cherniack, R. ;
Similowski, T. ;
Cleland, J. ;
Whitehead, A. ;
Wise, R. ;
McGarvey, L. ;
John, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) :775-789
[4]   Observational Study of Inhaled Corticosteroids on Outcomes for COPD Patients with Pneumonia [J].
Chen, Dennis ;
Restrepo, Marcos I. ;
Fine, Michael J. ;
Pugh, Mary Jo V. ;
Anzueto, Antonio ;
Metersky, Mark L. ;
Nakashima, Brandy ;
Good, Chester ;
Mortensen, Eric M. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (03) :312-316
[5]   Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results [J].
Crim, C. ;
Calverley, P. M. A. ;
Anderson, J. A. ;
Celli, B. ;
Ferguson, G. T. ;
Jenkins, C. ;
Jones, P. W. ;
Willits, L. R. ;
Yates, J. C. ;
Vestbo, J. .
EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (03) :641-647
[6]   Systemic Inflammatory Pattern of Patients With Community-Acquired Pneumonia With and Without COPD [J].
Crisafulli, Ernesto ;
Menendez, Rosario ;
Huerta, Arturo ;
Martinez, Raquel ;
Montull, Beatriz ;
Clini, Enrico ;
Torres, Antoni .
CHEST, 2013, 143 (04) :1009-1017
[7]   Clinical Trial Design for Mild-to-Moderate Community-Acquired Pneumonia-An Industry Perspective [J].
Echols, Roger M. ;
Tillotson, Glenn S. ;
Song, James X. ;
Tosiello, Robert L. .
CLINICAL INFECTIOUS DISEASES, 2008, 47 :S166-S175
[8]   Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia [J].
Gadsby, Naomi J. ;
Russell, Clark D. ;
McHugh, Martin P. ;
Mark, Harriet ;
Morris, Andrew Conway ;
Laurenson, Ian F. ;
Hill, Adam T. ;
Templeton, Kate E. .
CLINICAL INFECTIOUS DISEASES, 2016, 62 (07) :817-823
[9]   The host immune response contributes to Haemophilus influenzae virulence [J].
Geelen, Tanja H. ;
Gaajetaan, Giel R. ;
Wouters, Emiel F. ;
Rohde, Gernot G. ;
Franssen, Frits M. ;
Grauls, Gert E. ;
Stobberingh, Ellen E. ;
Bruggeman, Cathrien A. ;
Stassen, Frank R. .
RESPIRATORY MEDICINE, 2014, 108 (01) :144-152
[10]  
Global Initiative for Chronic Obstructive Lung Disease, 2015, GLOBAL STRATEGY DIAG